Evidence map›Paper›PMID 39336578›Full record

ArticleMedicina (Kaunas, Lithuania)2024

Development of a Short-Term Embolic Agent Based on Cilastatin for Articular Microvessels.

Hyun Jin Kim, Areum Jeon, Eun Kyung Kang, Wen An, So Jung Lim, Kyu Chul Shin, Dong Hun Shin, Inyoung Hwang, Ju Seop Kang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Imipenem/Cilastatin in Embolization: From Antibiotic to Therapeutic Agent.Cardiovascular and interventional radiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hyun Jin KimDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.ORCID 0000-0002-9742-0508
Areum JeonDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.
Eun Kyung KangDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.
Wen AnDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.
So Jung LimDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.
Kyu Chul ShinCheil Orthopedic Hospital, 726 Yeongdong-daero, Gangnam-gu, Seoul 06075, Republic of Korea.
Dong Hun ShinS&J Core Inc., 9 Yeongdong-daero 106-gil, Gangnam-gu, Seoul 06170, Republic of Korea.
Inyoung HwangDepartment of Clinical Pharmacology and Therapeutics, Hanyang University Seoul Hospital, Seoul 04736, Republic of Korea.ORCID 0000-0003-4953-759X
Ju Seop KangDepartment of Pharmacology, College of Medicine, Hanyang University, Seoul 04736, Republic of Korea.ORCID 0000-0002-5588-8663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CilastatinProtease InhibitorsAnimalsEmbolismEmbolization, TherapeuticIohexolMaleMannitolMicrovesselsParticle SizeRabbitsRatsRats, Sprague-DawleyCilastatinIohexolMannitolProtease InhibitorscilastatinD-mannitolembolic agentshort-term embolic efficacy

Identifiers

PMID39336578
PMCPMC11434490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.